INTERCEPT PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross in USD from Q4 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
Intercept Pharmaceuticals, Inc. quarterly Property, Plant and Equipment, Gross history and growth rate from Q4 2011 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Property, Plant and Equipment, Gross for the quarter ending September 30, 2023 was $2.15M, a 56.8% decline year-over-year.
Property, Plant and Equipment, Gross, Quarterly (USD)
Property, Plant and Equipment, Gross, YoY Quarterly Growth (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Property, Plant and Equipment, Gross (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $2.15M -$2.83M -56.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $2.14M -$16.1M -88.2% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $4.79M -$18.4M -79.4% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $4.79M -$16.6M -77.6% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 $4.99M -$18.2M -78.5% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $18.2M -$5.06M -21.8% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $23.2M -$34K -0.15% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $21.4M -$1.8M -7.74% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $23.2M +$2.36M +11.3% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $23.3M +$3.8M +19.5% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $23.2M +$4.02M +20.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $23.2M +$4.3M +22.7% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $20.9M +$2.09M +11.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $19.5M +$725K +3.87% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $19.2M +$757K +4.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $18.9M -$3.45M -15.4% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $18.8M -$3.51M -15.8% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $18.7M -$3.57M -16% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $18.5M -$4.63M -20% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $22.4M -$2.61M -10.5% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $22.3M -$3.3M -12.9% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $22.3M -$1.4M -5.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $23.1M +$3.65M +18.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $25M +$9.16M +57.9% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $25.6M Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $23.7M Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $19.5M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $15.8M +$3.4M +27.4% Dec 31, 2016 10-K 2018-02-28
Q4 2015 $12.4M +$5.88M +90% Dec 31, 2015 10-K 2017-03-01
Q4 2014 $6.53M +$4.57M +232% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $1.97M +$1.15M +142% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $934K +$135K +16.9% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $852K Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $822K Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $813K -$1.01M -55.3% Dec 31, 2012 10-K 2014-03-14
Q3 2012 $799K Sep 30, 2012 10-Q/A 2012-12-21
Q4 2011 $1.82M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.